Susquehanna International Group
IBIO icon

Susquehanna International Group’s iBio IBIO Stock Holding History

Susquehanna International Group’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$784K Buy
+412,725
New +$958K ﹤0.01% 8523
2025
Q4 		– Sell
-44,471
Closed -$36.8K – 12905
2025
Q3 		$36.8K Buy
+44,471
New +$34.2K ﹤0.01% 11938
2025
Q2 		– Sell
-32,413
Closed -$130K – 13131
2025
Q1 		$130K Buy
+32,413
New +$126K ﹤0.01% 11334
2023
Q4 		– Sell
-788
Closed -$3.44K – 12763
2023
Q3 		$4.78K Buy
+788
New +$6.81K ﹤0.01% 11794
2023
Q1 		– Sell
-6,742
Closed -$173K – 12979
2022
Q4 		$59.9K Buy
6,742
+5,606
+493% +$190K ﹤0.01% 11292
2022
Q3 		$97K Buy
1,136
+39
+4% +$5.37K ﹤0.01% 11733
2022
Q2 		$145K Buy
1,097
+597
+119% +$89.7K ﹤0.01% 11066
2022
Q1 		$107K Sell
500
-1,865
-79% -$390K ﹤0.01% 11859
2021
Q4 		$649K Buy
2,365
+133
+6% +$50.7K ﹤0.01% 8458
2021
Q3 		$1.18M Sell
2,232
-523
-19% -$326K ﹤0.01% 7119
2021
Q2 		$2.08M Sell
2,755
-236
-8% -$172K ﹤0.01% 5831
2021
Q1 		$2.3M Buy
2,991
+853
+40% +$743K ﹤0.01% 5582
2020
Q4 		$1.12M Buy
2,138
+859
+67% +$700K ﹤0.01% 6452
2020
Q3 		$1.3M Buy
+1,279
New +$1.85M ﹤0.01% 5498
2020
Q2 		– Sell
-173
Closed -$92K – 10463
2020
Q1 		$92K Buy
+173
New +$66.6K ﹤0.01% 9376
2018
Q2 		– Sell
-10
Closed -$11K – 9938
2018
Q1 		$11K Buy
+10
New +$10.5K ﹤0.01% 9177
2017
Q4 		– Sell
-19
Closed -$31K – 9533
2017
Q3 		$31K Buy
19
+10
+111% +$16.1K ﹤0.01% 8611
2017
Q2 		$18K Buy
+9
New +$17.6K ﹤0.01% 9033
2016
Q2 		– Sell
-3
Closed -$9K – 8872
2016
Q1 		$9K Buy
+3
New +$8.6K ﹤0.01% 8885
2015
Q1 		– Sell
-3
Closed -$9K – 9622
2014
Q4 		$9K Buy
+3
New +$16K ﹤0.01% 9523

Other funds holding IBIO

AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Susquehanna International Group's IBIO Position: Q1 2026 in Review

Susquehanna International Group opened a new position in iBio (IBIO) in Q1 2026: 412,725 shares worth $784K. The stake represents ﹤0.01% of the portfolio and ranks #8523 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in IBIO as recently as Q3 2025.

Susquehanna International Group first reported a position in IBIO in Q4 2014 and has held it in 20 quarters since. The position peaked at $2.3M in Q1 2021. 52 funds tracked by Wall St. Rank hold IBIO as of Q1 2026.

  • Susquehanna International Group held 412,725 shares of iBio worth $784K as of Q1 2026.
  • iBio was a new Susquehanna International Group position in Q1 2026.
  • iBio made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8523 holding.
  • Susquehanna International Group first reported a position in iBio in Q4 2014 and has held it in 20 quarters since.
  • Susquehanna International Group's iBio position peaked at $2.3M in Q1 2021.
  • 52 funds tracked by Wall St. Rank held iBio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.